Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven®) after allogenic bone marrow transplantation

被引：19

作者：

Karimi, M ^{[1
]}

Zakerinia, M

Khojasteh, HN

Ramzi, M

Ahmad, E

机构：

[1] Shiraz Univ Med Sci, Hemostasis & Thrombosis Unit, Hematol Res Ctr, Dept Pediat,Nemazee Hosp,Sch Med, Shiraz, Iran

[2] Shiraz Univ Med Sci, Sch Med, Bone Marrow Transplant Unit, Dept Internal Med, Shiraz, Iran

[3] Shiraz Univ Med Sci, Sch Med, Nemazee Hosp, Dept Urol, Shiraz, Iran

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 10期

关键词：

D O I：

10.1111/j.1538-7836.2004.00917.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1853 / 1855

页数：3

共 15 条

[1] The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications [J].

Baudo, F ;

Redaelli, R ;

Caimi, TM ;

Mostarda, G ;

Somaini, G ;

de Cataldo, F .

THROMBOSIS RESEARCH, 2000, 99 (01) :21-24

[2]

FIRLIT CF, 1973, J UROLOGY, V110, P57, DOI 10.1016/S0022-5347(17)60114-9

[3] Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy:: a double-blind placebo-controlled andomised trial [J].

Friederich, PW ;

Herny, CP ;

Messelink, EJ ;

Geerdink, MG ;

Keller, T ;

Kurth, KH ;

Büller, HR ;

Levi, M .

LANCET, 2003, 361 (9353) :201-205

[4]

FRIEDERICH PW, 2003, LANCET, V18, P361

[5]

Gallistl S, 1999, THROMB HAEMOSTASIS, V81, P245

[6] Successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation [J].

Hattori, K ;

Yabe, M ;

Matsumoto, M ;

Kudo, Y ;

Yasuda, Y ;

Inoue, H ;

Minami, S ;

Miyakita, H ;

Kawamura, N ;

Komori, K ;

Yamamoto, I ;

Yabe, H .

BONE MARROW TRANSPLANTATION, 2001, 27 (12) :1315-1317

[7] Clinical use of recombinant FVIIa (rFVIIa) [J].

Hedner, U ;

Ingerslev, J .

TRANSFUSION SCIENCE, 1998, 19 (02) :163-176

[8] Control of life-threatening pulmonary bleeding with activated recombinant factor VII [J].

Kamphusien, PW ;

van den Akker, JM ;

Kaasjager, KAH ;

Bloemen, TIFM .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :332-333

[9] A new approach to treatment of bleeding episodes in young hemophilia patients:: a single bolus megadose of recombinant activated factor VII (NovoSeven®) [J].

Kenet, G ;

Lubetsky, A ;

Luboshitz, J ;

Martinowitz, U .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) :450-455

[10] Treatment of traumatic bleeding with recombinant factor VIIa [J].

Kenet, G ;

Walden, R ;

Eldad, A ;

Martinowitz, U .

LANCET, 1999, 354 (9193) :1879-1879

← 1 2 →